Beta-2 Agonists Tied to ASD Risk? - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.

  • By

  • Andrea Surnit

  • June 24, 2026

  • 4 min

Share

Original Source(s)

Beta-2 Agonists Tied to ASD Risk?

  • by Andrea Surnit

  • June 24, 2026

Related Content

Fertility Issues May Be Linked to Autism

In a nationwide US cohort, parental subfecundity was associated with higher odds of autism spectrum disorder and modest increases in behavioral symptoms, while in vitro fertilization showed no statistically significant associations with neurodevelopmental outcomes.

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

Certain Surgical Specialties See Greater Attrition

“Nearly one in every 10 surgeons left active clinical practice.”